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Pasteurella multocida causes diseases in many animal
species including fowl cholera, a septicemic diseaseof
poultry and other birds.Pathogenesis of the disease has
been studied by many investigators by thesystemic
administration of the organism in poultry.However, only a
few studies have been done as to the respiratory
pathogenesis of the organism.The objective of the study
was to investigate the fate of P.multocida after the
intratracheal administration in turkeys
The fate of four strains of Pasteurella multocida was
studied after their intratracheal inoculation in youngadult
turkeys.Viable bacterial counts were made in respiratory
tissues as well as in the liver, spleen and blood at 6 and9
hrs after the inoculation of approximately109 viable
organisms of each strain.A virulent, encapsulated strain,
P-1059, invaded systemically by 6 hrs postinoculation(PI)and multiplied vicorously in all tissues and organs
examined.A blue colony mutant of P-1059, T-325, which does
not possess a thick layer of capsule, as well as CU vaccine
strain, invaded the parenchymal organs, but did not show
significant increase in viable counts at 9 hrs PI compared
with at 6 hrs PI.Another vaccine strain, M-9, also invaded
blood and internal organs by 6 hrs PI, however, its viable
counts showed no significant change between 6 and 9 hrs PI,
or in some tissues significant decrease at9 hrs PI.The
results indicate that all the four strains possess high
capacity to invade respiratory tissues with varying capacity
to persist in host tissues.
The lesions caused by two strains of Pasteurella
multocida (P-1059 and M-9) were observed after their
intratracheal inoculation in young adult turkeys.The
lesions were observed in the respiratory organs at 0,0.25,
0.5,1,2,3,and 6 hrs after inoculation of approximately
109 viable oraanisms of each strain. Both virulent strain,
P-1059 and non-virulent vaccine strain, M-9, have capacity
to invade and multiply in the tissues examined.
Macroscopicly, the lesions in the lung and in the airsac
were found as early as 1 hr PI, including the infected lung
was foamy and the airsac became cloudy.They became more
severe by 2 to 6 hrs PI. Microscopicly, heterophiles were
present, occasionally, in the lung, trachea and airsac by 0
to 1 hr after inoculation.Then they became more severe by
2 to 6 hrs PI.By 6 hrs PI, there werediffuseheterophiles infiltration in the trachea, lung, and airsac.
The lung vascular was edema. The trachea ciliate andmucous
gland was cystic or hyperplasia, and the airsac showed
increased in thickness and cloudiness. These results of
study indicate that the lesion caused by P-1059 and vaccine
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Chapter I
Introduction
(Literature review)
The Organism
Pasteurella multocida has been recognized as an
important veterinary pathogen for over a century, and its
pathogenic importancehas been increasingly recognized in
the last 50 years.The organism causes acute septicemia
with high mortality including hemorrhagic septicemia in
cattle and fowl cholera in poultry (Bain, 1963; Rhoades &
Rimler, 1991), or non-septicemic diseases including shipping
fever in cattle, pneumonia in sheep and goats, pneumonia and
rhinitis in swine and chronic upper respiratory infection
(snuffles) in rabbits (Carter and Bain, 1960).The oraanism
can also occur as a commensal in the naso-pharyngeal region
of apparently healthy animal of many species, and it can be
either a primary or secondary pathogen in a variety of
domestic or feral mammals and birds (Grief: et al., 1986).
Infection in human can occur most frequently after being2
bitten or scratched by infected animals suchas cats or dogs
(Yeff, 1983). The clinical picture includes a cellulitis,
bronchitis, pneumonia, and pleuralempyema (Griefz et al.,
1986) .
Pasteurella multocida is a Gram-negative, non-motile,
non-sporcgenous, coccobacillus, and the cell occurs singly,
in pairs or occasionally as a chained filament(Krieg,
1984). Virulent strains of P. multocidaare usually
encapsulated and the capsule can beseen in tissues from
infected animals and from laboratory cultures(Rimler and
Rhoades, 1989). The capsule contains carbohydrate and
other materials and differs in size.They are frequently
lost upon repeated passages in vitro (Heddleston,1962)
Generally, description of colonies are made from 18-24
hrs cultures incubated aerobically at 35-37C on enriched
media, containing serum, bloodor dextrose starch (Carter
1981; Rhoades and Rimier, 1989). Under these conditions,
colonies usually range in size from 1.0 to 3.0mm in
diameter. Two principal colony forms, mucoid and smooth,
have been recognized with no hemolysis. It doesnot grow on
MacConkey agar. Metabolically, the organism is catalase-
positive, oxidase-positive, indole-positive,and urease-
negative. On the triple sugar iron medium (TSI)it
produces an acid slant and acid butt withno gas/H2S
(Heddleston, 1964; Carter, 1967; Oberhofer, 1981) . The
large colonies are mucoid and composed of cellswith capsule3
consisting in part of hyaluronic acid (Jasmin, 1945). The
mucoid characteristic can range from a culture whose
colonies are discrete, circular, convex or having slight
mucous like consistency to a culture whose colonies are
confluent. The latter colonies, sometimes referred to as
watery mucoid colonies, possess flowing margin.
Observation of the colonial morphology on
semitransparent media under obliquely transmitted light with
a stereomicroscope gives useful characteristics of P.
multocida that distinguish variants (Elbert 1950;
Heddleston, 1964). Except for watery mucoid colonies which
appear gray, colonies consisting of capsulated cells display
a yellowish green, bluish-green of pearl-like iridescence
(Heddleston, 1964; Rhoades & Rimler, 1991).Colonies that
consist primarily of noncapsulated cellsare not iridescent
and appear blue, grayish-blue, or grey. Dissociation,
which is manifested primarily by a change froman iridescent
to a blue-grayish-blue colony forms, is often associated
with the loss of the bacterial capsule (Heddleston, 1964).
Antigen and Serology
Serological classification of P. multocida is
complicated because of its antigenic complexity (Brogden and
Packer, 1970). Various investigators havedeveloped
different serological methods, butno international
classification system has yet been established (Brogden&4
Packer, 1970; Heddleston, 1972).By convention, most
workers use Carter's indirect hemagglutination method
(Carter, 1955) for typing the capsular antigen and
Heddleston's gel diffusion method(Heddleston et al.,1970)
for typing the somatic antigen. Capsule types of P.
multocida can be separated into five serological groups (A,
B,D,E or F) by the indirect hemagglutination test.
Sixteen somatic types (type 1 through 16) have currently
been recognized by the immunodiffusion test with antiserum
against purified LPSs (Rimler & Rhoades, 1987). Capsular
types B and E strains of P. multocida are the frequent cause
of hemorrhagic septicemia in cattle (Carter & Bain, 1960).
Most strains associated with acute fowl cholera belong to
capsular type A, but their somatic antigens are
heterogeneous (Carter, 1967; Rimler and Rhodes, 1987).
To eliminate difficulties and time involved with the
indirect hemagglutination test, Carter and Rudle (1975)
developed a simple test in which serogroup A strains are
recognized by depolimerization of the capsule after growth
in proximity to hyaluronidase-producing strain of
Staphylococcus aureus. The basis for the presumptive
recognition of the serogroup D isolate is the characteristic
floccular reaction with acriflavine (Carter and Subronto,
1979).However, Rimler and Rhoades,(1987) found that
newly recognized serogroup F strains reacted similarly.
Characteristic mucoid colonies, due to the presence of5
hyaluronic acid in the capsule, has beenfound in most
capsule type A and a few type D strains (Carter,1967).
Most strains of P. multocida that producecolonies of large
watery mucoid variety have been found to belongto serogroup
A or D (Carter, 1967).Some colonies of capsular types A, D
or F strains display pearl-like iridescence under oblique
transmitted light.Subgroup B and E strains produce small
capsule and form smooth colonies that usuallyhave
yellowish or bluish-green iridescence (Rhoadesand Rimier,
1989).The presence of capsule is notan absolute criterion
for virulence of P. multocida becausecapsulated or non-
capsulated strains may be virulent.However, Penn and Nagy
(1974) reported transformationof colonies from iridescence
to noniridescence and concomitant loss of capsuleare
associated with reduction or loss of virulencein some
strains (Heddleston et al., 1964).
The capsule antigen of P. multocida responsiblefor
capsular types specificity is intimately associatedwith
lipopolysaccharide (LPS), as well as with non-antigenic
polysaccharide material.Both capsule specific antigen and
LPS are adsorbed onto erythrocyte from crudecell extract
(Rimier and Rhoades, 1991). However, the indirect
hemagglutination test with serum containing antibodyagainst
each usually shows a reaction only withthe capsule-specific
antigen.Carter (1955) reported that LPS and capsule-
specific antigen are considered to be identicalin some6
report, but the exact chemical composition of the surface
antigens is unknown. Despite the importance of the capsule
specific antigen, few studies have been aimed at determining
its composition.After heating crude extract at 56 C for 30
min, the antigen is retained and can be adsorbedonto
erythrocytes.Lipopolysaccharide can be extracted from the
cell by using the hot phenol-water method of Wesphal and
Jann (1965) and precipitated from the aqueous phase with
ethanol.Knox and Bain (1960) characterized preparation of
capsular polysaccharides isolated from supernatant fluid by
ethanol precipitation after removing the pH 3.8 isoelectric
precipitates.Protein was removed from final product by the
trypsin treatment.Althoughthe substance was antigenic
and non toxic, the best polysaccharide preparationare
heterogeneous and formed two precipitin lines inan
immunodiffusion test.It contained fructose, mannose and
glucosamine.The polysaccharide containing fructose was
produced by both an iridescent and noniridescent variant of
strain. Penn and Nagy (1976) isolated capsule antigen from
serogroup B and E strains.The nontoxic antigens were
isolated by fractional precipitationfrom aqueous solution
with polar solvents.The chemical composition of the
antigens were not established.However, they were assumed
to be acidic polysaccharides of high molecule weights, based
upon gel filtration chromatography, precipitation with ethyl
pyridium chloride, insensitivity topronase and nonreaction7
with protein stains (Rimler and rhoades, 1991)
Pasteurella multocida LPS have chemical and biological
properties similar to those found in many species of Gram-
negative bacteria.As an antigen LPS has been associated
with protection of animals and is believed to be the
chemical basis for specificity of somatic typing system. It
has been studied as a purified formor in association with
protein as complexes.Prosky (1938) was able to extract
LPS-protein complexes from two or three strains of P.
multocida using three chloroacetic acid.The complexes were
characteristics of Boivin type antigen (endotoxin) being
both immuncaenic and toxic.Rabbit antiserum, made against
the antigen, produced active immunity in mice against the
endotoxin challenge.SiMilar complexes were extracted from
fowl cholera strains (serotype 1 and 3) and a bison
hemorrhagic septicemia strain (serotype 2)with formaldehyde
saline solution (Heddleston at al., 1966; Rebers et al.,
1966).After purification by ultracentrifugation, the
complexes had endotoxin activity and induced serotype
specific active and passive immune protection against the
challenge with live organisms.
Galancs et al.(1969) made a preparation of LPS from
ethanol-killed cells that had been washed and dried.Cells
killed by formalin have been used, but the use of formalin
has resulted in alteration of extractibility, toxicity and
chemical composition of LPSfrom certain strains (Rebers8
and Rimier 1984).Extraction is done by the phenol-water
method of Westphal and Jan (1965) or
phenol:chloroform:petroleum ether (PCP) method of Galanos et
al.(1965).The presence or the absence of the capsule
seems to have no influence on extractibility by either
method. Lipopolysacccharides can be extracted frommost
strains by one of the methods but not both.With the other
strains, either method can result in comparable yield.
Because cells are not destroyed by the PCP method,they can
be recovered, washed with diethyl ether and dried foruse in
the phenol-water method. All LPS contain lipidA, glucose,
heptose, and 2-keto-3 deoxy octanate (KDO), and glucosamine
(Erler et al., 1977).Rimier et al.(1984)reported that
buoyant densities of P. multocida LPS determinedby
ultracentrifugation in cesium chloride gradientwere about
14 g/ml; the LPS caused direct hemagglutination withchicken
and turkey erythrocytes but not with horse and sheep
erythrocytes (Rimier, 1984). Purified P. multocidaLPS is
antigenic and can react with avian and mammalianantisera
made against the whole organism.An immunoprecipitation
line of partial identity usuallyoccurs with LPS and
specific heat-stable antigen of the Heddlestontype system
(Rhoades and Rimier, 1989).Rimier (1984) found that LPS
from some serotypes produce antibodies in chickenwhereas
others did not. Rebers (1980) found that antibodiesmade
against purified LPS of avian strains protectedchicken9
against challenge with the homologous organism.
Fowl Cholera
Fowl cholera is an acute septicemic disease withhigh
morbidity and mortality whichmay affect many types of birds
throughout the world (Rhoades & Rimler, 1991).The disease
has also been called avian cholera, avianpasteurellosis, or
avian hemorrhagic septicemia.Strains of capsular serotype
A of P. multocida are recognizedas the cause of fowl
cholera (Carter 1967; Rhoades and Rimler, 1987).
Fowl cholera is widely distributed geographically,
occurring in most poultry producing countriesof the world.
The occurrence of the disease is frequentor sporadic
depending on location and prevalence fromyear to year.
Poultry, particularly the chicken, turkey,pheasant, duck,
and goose, are commonly affected andmost reports on disease
occurrence and research are concerned with these hosts.
However, the disease is also of major importance insome
wild birds.
The degree of susceptibility variesamong different age
groups within a species.Turkeys and pheasants are more
susceptible than chickens (Heddleston, 1962;Curtis et al.,
1980).Generally speaking, older chickens and turkeyswere
more susceptible to fowl cholera thanyounger ones
(Heddleston, 1962; Hangerford, 1968).The natural disease
does not occur in chickens or turkeys of5 weeks of age or10
younger.
Thetranmission of the disease within a flock is
considered to be primarily through direct or indirect
contact, including exposure to water or feed contaminated by
infected members of the flock.Generally, the manner in
which a flock becomes infected is unknown.However, a
number df potential sources of infection have been
recognized.Chronically affected birds in poultry flocks
may shed the organism for years, and serve as a source of
infection for susceptible birds (Van and Olney, 1940; Hall
et al, 1955).Wilds birds and mammals mayoften serve as
carriers of the disease (Snipes et al., 1987).
Commcn clinical signs include depression, ruffled
feathers, fever, anorexia, mucous discharge from the mouth,
diarrhea and high temperature.In some cases, such signs
are present only a few hours before death, so the first
observed evidence of disease is often death.Near the time
of death, birds often become cyanotic; the cyanosis is
particularly evident in the comb and wattle of chicken and
snoods and unfeathered skin of the head of turkeys.Fecal
materials from acutely affected bird is generallywatery and
predominantly white in early stage of disease and later
become predominantly green containingmucus.Rhoades and
Rimler (1991) found that signs in chronically infectedbirds
are usually associated with localized infection, involving
such structures as wattles, sinuses, preorbitalsubcutaneous11
tissues, leg or wing joints, sternalbursae and foot pads.
Exudative conjunctivitis and pharyngitisare also observed.
Pathogenesis
Pathogenicity or virulence of P.multocida in relation
to fowl cholera is complex and variabledepending on the
strain, host species and variation withinthe strain or host
and on the condition of contactbetween the two.The
ability of P. multocida to invadeand reproduce in the host
is related to a capsule thatsurrounds the organism.
Portal of entry of P. multocida innatural infection in
poultry is probably the pharynx and/orupper respiratory
tract (Hughes, 1930 and Arsove, 1965),but it may also enter
through the conjunctivaor cutaneous wound.The rapid
multiplication of bacteria within thebird may produce an
acute fatal septicemia, and thecause of death is presumed
to beendotoxic shock (Hunter and Wobeter,1980).
Maheswaran et al.,(1971) demonstrated that when only5 x
104organism of virulent P. multocidawere endotracheally
inoculated into turkeys, the bacteriaemerged in blood and
spleen as early as 6 hrs after inoculation.The organism
appears to invade the mucosal epitheliumsoon after
colonization and enter the bloodstream.Pabs-Garnon and
Soltys (1971) demonstrated that virulentP. multocida, when
inoculated intravenously into turkeys,initially localized
in the liver and spleen.The bacteria multiplied primarily12
in the two organs and were abruptly released intothe blood
stream at the terminal stage; resulting in septicemia.The
implication of this observation is that the bacteriamay be
trapped by the reticulo-endothelial phagocytes in the liver
and spleen, and multiplied intracellulary in thephagocytes.
Some histopathological evidence which support this viewhas
recently been reported (Wallner-Pendleton andMatsumoto,
1988).The manner by which infection of the lungs occurred
could not be ascertained by experimental inoculation
Rhoades & Rimier, 1990).Generally, infection did not
spread from colonized pharyngeal tissue to trachea.The
presence of a few organisms in the tracheasupportedthe
possibility that infection of the lungsmay be originated
from the air passage. Tsuji and Matsumoto (1989)
demonstrated that the blood-borne P. multocida in both
encapsulated and nonencapsulated form was rapidly removed
from the blood stream into the liver and spleenregardless
of the presence or absence of capsule.However,
encapsulation seemed to be essential for survivalof P.
multocida after being entrapped in the liveror spleen.
Gross and Histopathological Lesions
Lesions of fowl cholera are not constant butvary in
type and severity.The greatest variation is related to the
course of the disease, whether acute or chronic.with the
former, postmortem lesions are associated withvascular13
disturbances.General hyperemia is most evident in veinsof
the abdominal viscera, and may be quitepronounced in small
vessels of the duodenal mucosa.Petechial and ecchymotic
hemorrhages are frequently found andmay be widely
distributed.Subepicardial and subserosal hemorrhagesare
common, as are hemorrhages in the lung, abdominal wall, and
intestinal mucosa (Rhoades, 1964).Disseminated
intravascular clotting causing fibrinous thrombosishas been
observed in chickens and ducks that died fromacute
experimentally induced fowl cholera (Hunterand Wobeser,
1980; Park, 1982).
The liver of acutely affected birdsmay be swollen and
usually contain multiple, small focalareas of coagulative
necrosis and heterophilic infiltration.However, some of
less virulent Pasteurella multocida donot produce necrotic
foci in the liver (Rhoades & Rimier,1991).Rhoades (1964)
had shown heterophilic infiltration alsooccurred in lungs
and certain other parenchymatousorgans. The lung of
affected birds may be partly or completelyconsolidated,
dark red and covered by a yellow exudate.The consolidation
is due to a massive exudation of fibrinand heterophiles
affecting all parts of lungs, includingthe pleura. The
lung of turkeys are affectedmore severely than those of
chicken, with pneumonia beinga common sequela.
Prantner et al. (1991 )reported that in the lungs
after 16 to 24 hrs inoculated witha highly virulent field14
isolated of P. multocida serotype A:3,4 (86-1913)by an
oculo-nasal-oral route, large bronchiwere completely filled
with bacteria, fibrin, and a few necroticheterophils.The
parabronchi were distended by a loose networkof fibrin,
degenerated heterophils, and large number of bacteria.
Changes in pulmonary veins and small arteriesincluded
fibrinoid necrosis, subendothelial accumulationof
heterophils (Prantner et al., 1991).Large amounts of
viscid mucus were observed in the digestivetract
particularly in the pharynx,crop, or intestine.Prominent
splenic changes occurred at 16 to 24 hrspostinoculation and
varied in severity among individual birds.There was
degeneration of periartericlar reticularcells; these cells
progressed to by coalescing areas of coagulativenecrosis
containing solid sheets of extracellularbacteria and
heterophils.Hungerford (1968) reported therewas catarrhal
exudates in mass passage and in the wind pipe;the air sacs
may be partly filled with caseous material.
Chronic lesion is usually characterizedby localized
infection in contrast to the septicemicnature of the acute
disease.They often occur in the respiratorytract and may
involve any part including sinuses andpneumatic bones.
Pneumonia is an especiallycommon lesion in turkeys.
Chronic localized infectioncan involve the middle ear and
cranial bones and can result in torticollis (McCune and
Olsen, 1974).Affected birds have acaseous exudate filling15
many of air spaces around the middle air in the cranium.
The exudate consists primarily of fibrin and heterophiles.
In some areas, the cell may become necrotic and forman
eosinophilic mass contaihing nuclear debris and surrounded
by giant cell (Olson et al., 1966).
Immunity
Successful induction of active acquired immunity
against fowl cholera has been observed by Pasteur in 1881.
This attempt to immunize against the diseasewas
accomplished using an attenuate bacterial strain.Later,
attempts to immunize poultry generally involved theuse of
bacterin (inactivated whole bacteria) whichwere often
combined with adjuvant.Bacterins continue to be widely
used commercially and are generally efficacious. Heddleston
(1970) demonstrated that immunity induced by the bacterinis
limited within somatic types of strain. There isa good
correlation between immunotype and somaticserotype
determined by the procedure of Heddleston et al.(1972)
which utilizes bacterial LPS as an antigen (Brodgenand
Rebers, 1978).Because of the relationship between
immunotype and somatic serotype,the LPS antigen is
considered an important contributor to the immunity induced
by bacterins (Rebers et al., 1980 ;Rimler and Philips,
1986).Immunity induced by bacterins, however,covers only
limited antigenic scope and is short-lived.Live vaccine16
strainM-9 and Minnesota (MN) strains are safe, generally
effective and offer immunity against wider antigenic
diversity than bacterins do, but the induced immunity lacks
in duration andintensity (Matsumoto, 1989; Friedlander et
al., 1991).Other live vaccines such as CU, PM#1, and #3,
mostly belonging to serotype 3,4, have been used in various
parts of the country.Immunity induced by a live vaccine is
cross-protective against the challenge infection with the
heterologous somatic serotype strains of P. multocida
(Bierer et al., 1979).A serious disadvantage of this
vaccine is that the vaccine strain of P. multocida, by
itself, appears to cause significant mortality when it is
administered to the bird under undefined stressesor
immunosuppressive conditions.
The mechanism by which active acquired immunity
prevents development of fowl cholera is not well understood.
Both humoral and cell immediated immunityare considered
important contributors.Since immunity can be passively
transferred to susceptible birds using eitherserum or
serum-globulin from immunized birds (Rebers et al., 1975;
Rimler, 1987), humoral factors playa major role. However,
Tsuji and Matsumoto (1990) indicated thata macrophage-
stimulating factor enhances bactericidal activity againstP.
multocida17
Chemotherapy
Anti-bacterial chemotherapy has been used extensively
in treatment of fowl cholera with varyingsuccess, depending
tolarge extent on the promptness of treatment and thekind
of drugs used.Sensitivity testing is often advantageous if
it is done in a prompt manner, since strainsof P. multocida
vary in susceptibility to chemotherapeutic agents and
resistence to treatment may develop, especiallyduring
prolonged use of a drug. The therapeutic agentsare
effective in improving clinical disease of fowlcholera,
especiallyby decreasing mortality.However, none of the
drugs with any means of application is usefulfor the
complete recovery of affected birds.Some reports indicated
that P. multocida multiplies in phagocytes of liverand
spleen and also can localize in joints and cerebrospinal
spaces as well ason the surface of the respiratory tract.
The ineffectiveness of the drugs may be explainedby the
intracellular localization of the organism (Matsumoto,
1989).Sulphonamides have been employed both experimentally
and in natural outbreak.The main disadvantage of
sulphonamides are their bacteriostatic instead of
bactericidal action, inability tocure localized abscesses
and toxic effect on birds.Kiser (1948) reported 63-85
percent reduction in mortality from experimentally produced
fowl cholera compared to the untreated controlwhen using
sulfamethazine and sodium sulfamethazine.Favorable results18
were obtained with 0.5-1.0 percent of drug in food,or 0.1
percent in drinking water.
Administeration of penicillin, streptomycin,or
tetracyclin via an intramuscular route, all showed
therapeutic effects (Bierer, 1962 ).Little (1948)
reported that the use of chlortetracyclin reducedlosses in
chickens about 80 % when given at the rate of 40 mg/kg body
weight intramuscularly a half hour after parenteral
inoculation of the organism.19
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Chapter II
The invasive and Persisting Capacity of
Four StrainsofPasteurella Multocida
After The Intratracheal Inoculation into Turkeys26
Summary
The four strains of Pasteurella multocida, P-1059,T-
325, CU, and M-9 were used in this study.They are
intratracheally (IT) inoculated into turkeys, thenumber of
viable bacteria in the trachea, lung, liver,spleen and the
blood were enumerated during periods of 6 and 9 hrs
postinoculation (PI).The four strains of organism were
present in the organ and the tissues observed.In the
liver, spleen and blood, the virulent P-1059strain showed
significant increases within 6 or 9 hrs PI.Strain CU
showed significant increase only in the spleen.Two other
strains did not show significant increase inany organs;
strain M-9 ,on the other hand, showed sianificant decrease
in the trachea.These results indicated that P-1059, and
three other strains showed their abilityto invade the
tissues or organs when they are intratracheally(IT)
inoculated.27
Introduction
Fowl cholera is a bacterial disease of fowl andother
birds caused by Pasteurella multocida (Rhoades and Rimier,
1991). Economically, it causes significant worldwidepoultry
losses, including death loss, condemnation loss,and
vaccination and medication cost (Carpenteret al., 1988). A
Variety of vaccines are available, but have shownonly a
limited value in preventing the disease.Inactivated
vaccines (bacterins) induce only type-specificimmunity for
limited duration and must be applied individually
(Heddleston, 1972).Live vaccine strains are generally
effective when given in the drinking water (Biererand
Derieux, 1972), or the-wind web application (Marshall,
1981). However, various field observations havesuggested
that the live vaccines maycause substantial mortality as
well as persistent infection in vaccinates, whichmay serve
as a source of further infection (Schlink and Olson, 1987b).
Pathogenesis of fowl cholera is poorly understood. The
invasion of the organismoccurs primarily through the upper
respiratory tract mucosa (Rhoades and Rimler, 1991)or
through the lower respiratory tract (Ficken andBarnes,
1989).The organism in the blood is rapidly cleared and
localized in the liver and spleen. The virulent organism
rapidly multiplies in theseorgans and is abruptly released
again into the blood shortly before death of the host28
Pabs-Garnon and Soltys, 1971; Tsuji and Matsumoto, 1989).
Some attention has been focused on the initial adhesionand
invasion of the organism.. Maheswaran (1973)demonstrated
that when a low number of a virulent strainwere
endotracheally inoculated into turkeys, the bacteria emerged
in the blood and spleen as earlyas 6 hrs after inoculation.
Intraairsac inoculation of CU vaccine strainresulted in the
detection of the organism in the blood at 3 hrs
postinoculation (Ficken and Barnes, 1989).Rhoades and
Rimler (1990 )inoculated a virulent or CU vaccine strain
into the upper respiratory tract of turkeysand determined
the presence of the organism in various tissuesby the swab
culture method.They observed the systemic invasion of the
virulent organism at 12 hrs but not 6 hrs afterinoculation.
On the other hand, the CU vaccine strainshowed a
significantly lower invasion rate than the virulentstrain.
Matsumoto et al.(1991) found that the intratracheal
inoculation of a virulent strain in the order of 108to 10'
organisms showedthe organism multiplied in situ to
gradually spread downward to lower respiratorytract in the
first few hours. By 6 hrs, the organisms invadedthe blood
circulation to multiply vigorously in the liverand the
spleen in the majority of the inoculatedturkeys.
The purpose of this study was to investigate the
respiratory pathogenesis of four strains of P. multocidain
turkeys.The four strains were an encapsulated P-1059,non-29
encapsulated T-325 strain derived from P-1059, and two
vaccine strains, CU and M-930
Material and Methods
Experimental Turkeys. Medium white turkeyswere
maintained as a closed flock at the Departmentof Poultry
Science, Oregon State University (Haleset al., 1989).
Progenies of the flock were maintained ina brooder unit up
to seven weeks of age, andmoved to a concrete animal
isolation unit with wood shavingson the floor.
Bacteria: Pasteurella multocida, strain p-1059,was
originally obtained from Dr. K.R. Rhoades, National Animal
Disease Center, Ames, Iowa.Strain T-325 was a spontaneous
mutant lacking capsule derived from P-1059 strain(Tsuji and
Matsumoto, 1989).Strain CU was obtained from Kee Vet
Laboratories, Anniston, Alabama.Strain M-9 was obtained
from Dr. M. Jensen, Brigham Young University,Provo, Utah.
All strains were propagatedon dextrose starch agar (DSA;
Difco, Detroit, MI), harvested in brainheart infusion broth
(BHI; Difcc) and stored at 70 C.Characteristics of the
form strains are listed in Table 1.
Inoculation: Pasteurella multocida, strainP-1059, T-
325, CU, and M-9 were recovered from frozencultures to DSA
and incubated at 41 C (P-1059 and T-325)or 35 C (CU and M-
9)overnight. Bacteria were spread out forconfluent growth
on warmed DSA plates (100 x 15 mm) and incubated for 4hrs
at the appropriate temperature. The growthwas harvested
with 5 ml of BHI broth/plate and enumeratedfor viable
counts by plating out serial dilutionson DSA.The culture31
harvest of each strain diluted to 1:10 in BHIwas used as
inoculum.32
Table 11.1. Characteristics of the strains of P. multocida
used in the study
Strain Encapsulation Colony Optimal
Growth
Temperature
2-1059
T-325
CU
M-9
++'
-f-b_
++
+_
iridescent 41°C
blue 41°C
iridescent 35°C
blue/gray 35°C
a)
b)
a substantial amount of capsule present; bacteria cannot be
aggegated by antiserum
no capsule was visible by capsular stains; bacteria were
agglutinable by antiserum33
Intratracheal inoculation:The inoculum was transferred
into a 5 ml syringe, and polyethylene tubing (1.19mm in inner
diameter)in 5.1 cm length was attachedon 18 ga. needle.
The tubing was carefully inserted through the laryngealcleft,
and 2.5 cm (1 inch) below the cleft, the inoculum in 1 mlwas
delivered slowly drop wise.After inoculation, the headwas
held with the mouth open for1 minute to prevent immediate
expulsion of inoculum.
Sampling procedures:Blood was drawn in 5 ml from the
cutaneous ulnar vein into a syringe containing heparin (final
concentration;40 units/ml). The turkeys were killed by
electrical shock.A sterile cotton swab was inserted through
the platine cleft,rotated afew times,and streaked onto
sheep blood/MacConkey agar. The skin of the neckwas pulled
back and the trachea was exposed and a ring of 1cm width was
cut 2 cm below the laryngeal cleft for the upper tracheal
sample.At about 2 cm above the bifurcartion, a ring of 1cm
width was cut for the lower tracheal sample.For the rest of
isolation,the body was placed in the metal tray ata 30
degree angle with the head upward. The ribwas cut and the
sternum were reflected to expose the thoracic and abdominal
cavities.Swab samples were taken from thoracic and abdominal
airsacs and directly plated onto DSA plates.Blood vessels
were clamped off using hemostats, and the heart, liver, and
digestive tract were lifted out. A portion of the liverand
the entire spleen were removed.The right and the left lungs34
were removed.All the tissue samples were placed in sterile
plastic bags and immediately placed on ice.
Sample processing:Blood and tissue samples were
immediately processed as follows; the bloodwas transferred
to a sterile tube and mixed well.Serial 1:10 dilutions
were made in 0.05 M phosphate buffered saline (0.85%) pH 7.2
(PBS) by transferring 0.2 ml of blood to 1.8 ml of sterile
PBS.The appropriate dilution in 0.1 was spread outon DSA
plates and incubated.Broth culture was made by adding 1.0
ml of blood to 100 ml of sterile BHI broth and incubatingat
41 or 35 °C. Liver, spleen, and right/left lungswere
weighed.Sterile PBS in 9 ml was added for every 1g of
tissue to make the original 1:10 dilution.The sample was
then processed for 30 sec. in a homogenizer (Stomacher,Model
STO-80, Tekmar, Cincinati, Ohio).Serial 1:10 dilutions
were made and samples plated out by the same method as for
blood. Broth culturesfor tissues were made by adding 1.0
ml of the 1:10 dilution to 100 ml of BHI broth and incubated
at 41 or 35 °C.Upper trachea and lower trachea were
weighed and the amount of PBS to add for the 1:10 dilution
was determined in the same way as for other organ samples.
Trachea samples were then cut into small pieces using
sterile scissors, and placed into sterile mortars.A small
amount of sterile sand and predetermined amounts of sterile
PBS was added followed by grinding with pestles.The sample
was then poured into the test tube and placed on ice.35
Serial 1:10 dilutions were made andplated out by the same
method as for blood and the other organ samples.Colony
counts were made on all plates on the following day.If
they were still negative at 48 hrs the colony counts were
recorded as 0.If all the platesfor a sample were
negative, the broth culture was checked for signs of
bacterial growth.Subcultures of the positive broth
cultures were made in blood/MacConkey agar for
identification of P. multocida.The broth culture was
judged negative when no bacterial growth was observed after
48 hrs of incubation.When colonies of apparent pure
culture with mucoid appearance and strong iridescence were
observed, they were identified as P. multocida.When mixed
cultures or atypical colonies were observed, the following
criteria was used to identify P. multocida; characteristic
staining and morphology with gram stain, negativegrowth on
MacConkey agar, positive catalase test, weakly positive
oxidase test, acid slant/acid butt with no gas or H2S in the
triple sugar iron medium, and positive reaction for indole.
Experiment 1:Ten 8-week-old turkeys were inoculated
intratracheally (IT) with 1.3 x 109 CFU of P-1059.Five of
them were terminated at 6 or 9 hrs postinoculation, and
their tissues were examined for bacterial counts.Two
uninoculated control birds were also processed.
Experiment 2:Ten 9-week-old turkeys were IT
inoculated with 4.0 x 109 CFU of P. multocida strain T-32536
per bird.Other procedures were done in a same manneras in
Experiment 1.
Experiment 3:Ten 10-week-old turkeys were IT
inoculated with 1.3 x 10? CFU of strain CUper bird.Other
procedures were done in a same manner as in Experiment 1.
Experiment 4.Ten 12-week-old turkeys were IT
inoculated with 4.7 x 109 CFU of P. multocida strain M-9per
bird.Other procedures were done in a same manneras in
Experiment 1.
Statistical analysis:The colony counts were
transformed into logo values, and themean and standard
deviation were calculated in each group.Bac.:erial
concentration for the two interval times(6 and 9 hrs) were
compared using the Student's t-test.37
Results
Experiment 1.Turkeys were IT inoculated with 1.3 x
109 CFU of P-1059 and tissues were examined for bacterial
counts at 6 hrs and 9 hrs postinoculation (Fig II.1).No
Pasteurella was isolated from any tissue of the two
uninoculated control turkeys.All the birds showed evidence
of Pasteurella infection at 6 hrs PI; the organism was
isolated in high numbers in respiratory tissues and in
moderate numbers in the liver, spleen and blood.At 9 hrs
PI all birds showed high numbers of the organism in all
tissue samples.Between 6 and 9 hrs PI, there was a highly
significant (p<0.01) increase in the number of the organisms
isolated from the liver, spleen and blood (Table 11.2).The
data indicate that P-1059 strain invaded systemically before
6 hrs PI followed by the rapid multiplication in the liver
and spleen.Gross and histopatholcgical lesions are
described in the accompanied chapter.
Experiment 2.Turkeys were IT inoculated with non-
encapsulated T-325 strain and examined at 6 and 9 hrs PI
(Fig 11.2).The two uninoculated controls birds showed
negative isolation results with any tissues.At 6 hrs PI,
the bacteria were detected in high numbers in the
respiratory tissues and also in the systemic organs.
However, the number of organisms detected in the liver,
spleen and blood were smaller than those observed with P-
1059 strain.Three out of the five birds showed negative38
results with blood samples.At 9 hours PI, T-325 strain did
not show the vigorous multiplication in the systemic organs
as seen with P-1059 strain.In fact, the number of organism
in blood and liver, did show no significant difference
p>0.05 )between 6 and 9 hrs sampling time (Table 11.2).One
turkey showed less the 10 CFU/g in the blood at 9 hrs PI.
Experiment 3.Strain CU was IT inoculated and tissues
were examined at 6 and 9 hrs PI(Fig 11.3).No Pasteurella
was isolated from any tissues of the two control turkeys.
At 6 hrs PI the organism was abundant in respiratory tissues
similar to the observation with P-1059 or T-325 strain.As
with the case of T-325, no significant (p>0.05) increase of
the organism was seen in the blood or liver.In the spleen
,however, a significant (p<0.05) increase in the bacterial
number was observed.
Experiment 4.Turkeys were IT inoculated with M-9
strain and tissues were examined at 6 and 9 hrs PI (Fig
11.4).No organism was isolated from any tissue of the two
uninoculated control birds. The organism was isolated in
moderate numbers in the respiratory tissues at6 hrs PI.
Unlike the three other strains, significantly fewer (p<0.05)
organisms were detected at 9 hrs than 6 hrs PI in the upper
and lower trachea, the right lung and blood11
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Fig. II.1. Bacterial recovery (mean + standard deviation)
from the palatine cleft (PC), upper trachea (UP), left lung
(LL), right lung (RL), thoracis airsac (TAS), abdominal
airsac (AAS),liver(L) ,and spleen(S)of inoculation
turkeys at 6 or 9 hrs after intratraheal (IT) inoculation
with encapsulated P-1059 strain. (+)or (-)for PC, TAS,
and AAS shows positive or negative respectively, isolation
from a swab sample.11
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Fig. 11.2. Bacterial recovery (mean+ standard deviation)
from various samples of inoculated turkeysat 6 or 9 hrs
after IT inoculation of nonencapsulatedT-325 strain.
Abreviation for tissues are explained inFig II.1. (+)or
(-)for PC, TAS, and AAS shows positiveor negative,
respectively, isolation froma swab sample. (+*)or(-V)
indicates the result of broth culturewhen plate count was
less than 10 CFU/g.41
At 6 hrs PI,4 turkeys showed negative isolation with the
blood,1 with liver, and 1 with spleen.At 9 hrs PI,3 out
of 5 turkeys showed negative results with blood, and1 out
of 5 with spleen.42
Table 11.2. Summary of the statistical analysis using
two sample comparison test based on Ho. .16lIrs-11911rs for each
strain
Tissue
P. multocida strain
P-1059 CU T-325 M-3
Upper Trachea
Lower Trachea
Left Lung
Right Lung
Blood
Liver
Spleen
* *
**
)significant difference at 1% level
) significant difference at 5% level
non significant difference at 5% level11
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swab sample. (-1-')or(-')indicates the result of broth
culture when the plate countwas less than 10 CFU/g11
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Fig. 11.4. Bacterial recovery (mean + standard deviation)
from various samples of inoculated turkeys at 6 or 9 hrs
after IT inoculation of M-9 strain. Abbreviation for tissues
are explained in Fig. II.1.(+)or(-)for PC, TAS< and AAS
shows positive or negative, respectively, isolation from a
swab samples.(+*)or (-) indicates the result of broth
culture when plate count was less than 10 CFU45
Discussion
In the present study, high numbers (10'CFU) of viable
P. multocida were deposited on the surface of tracheal
mucosa.Our preliminary study indicated thateven a
virulent P-1059 strain caused systemic infectionat a low
rate when it was IT inoculated in lower than 108CFU.
Processing each tissue for accurate CFU counts technically
limited us to examine 12 bird in each experiment.The
combination of these two factorswere the reason for the use
of high inoculum amount topursue the main objective;
evaluating invasiveness of the four strains afterIT
inoculation.
Pasteurella multocida is suggested to invade theupper
respiratory mucosa to reach the blood stream (Rhoadesand
Rimler, 1991).When virulent P-1059 strainwas swabbed at
the palatine cleft, however, no systemic infectionwas
detected at6 hrs postinoculation (Rhoades and Rimler,
1990).Intratracheal inoculation of P-1059 strain resulted
in the detection in the liver as earlyas 3 hrs
postinoculation (Maheswaran, 1973).A live vaccine strain,
CU, was detectedin the. blood at 3 hrs after the
inoculation of the organism into the airsac (Fickenand
Barnes, 1989). When P-1059 strain was IT inoculated into
turkeys, it multiplied in situ, spreading Gradually
downwards along the airway in a majority of the animals,
while, in some animals, the organism invadedthe blood and46
systemic organs in less than one hour (Matsumotoet al.,
1991).In the present study, P-1059 and three other strains
showed their high rate of invasiveness when theywere IT
inoculated in high numbers, suggesting that there isnot a
significant difference among the four strains in their
capacity to cause systemic invasion from the respiratory
tract in the turkeys. The four strains, however, showed
differences in their capacity to multiply in variousorgans.
The statistical analysis shown in Table 2 indicates
there is differences among strains in their capacityto
multiply in various organs. Between 6 and 9 hrsof
isolation, P-1059 strain showed significant increasein
bacterial numbers in the blood, liver, and spleen. StrainCU
showed a significant increase only in the spleen.The other
two strains did not show a significant increase inany
organs. Strain M-9, on the other hand, showed significant
decrease between the two isolation attempts inthe upper and
lower trachea, right lung and the blood. Twofactors should
be considered for the cause of these differences.Strain P-
1059 and CU are encapsulated, while T-315 andM-9 are not or
poorly encapsulated; P-1059 or T-325grow optimally at 41 C,
while the two vaccine strains are temperature-sensitive
mutants, crowing optimally at 35 C. Differences in their
growth rate in the turkey combined withsome unknown
"protective" effect of the capsule from the hostdefense
mechanism may explain the observed differencesin the fate47
of the organism in vivo.
Pathogenesis and immunity in fowl choleraare poorly
understood.The organism invades from the respiratory
tract, enters the bloodstream, and localizes in the liver
and spleen (Pabs-Garnon and Soltys, 1971; Tsuji and
Matsumoto, 1989).Virulent organisms multiply rapidly in
these organs, while those belonging to low virulent strains
are killed at various rates (Tsuji and Matsumoto, 1989).In
immune turkeys, a virulent strain is killed in the liver
(Tsuji and Matsumoto, 1990) .The mechanism by which the
organism is killed in the liver is not known.The results
of the present study generally support these pathogenic
processes.In addition, the results indicate that both
virulent and current vaccine strains allpossess high
capacity to invade from the respiratory tract intothe
bloodstream.48
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Chapter III
The Lesions Caused by Pasteurella Multocida
Strain P-1059 and M-9
After Intratracheally Inoculated into
Turkeys51
Summary
Lesions caused by Pasteurella multocida strain P-1059
and M-9 were investigated in turkeys.The birds were
intratracheally (IT) inoculated with a virulent strain, P-
1059 or M-9 vaccine strain, and the lesions were observed in
the lung, trachea and airsac during period of 0,0.25, 0.5,
1,2,3, and 6 hrs PI.No serious lesions were found in the
early infection (0.25-1 hr).At later stages, the trachea
showed numerous heterophil infiltrations and hyperplastic
mucous glands.In the lung, there were intense infiltration
of heterophils and moderate to severe vessel edema. The
airsac showed increased thickness and cloudiness due to
infiltration of heterophils and edema.No major differences
were noted in the microscopic lesions between birds infected
with P-1059 and those infected with M-9 strain.These
result suggest that both P-1059 and M-9 vaccine strain have
an ability to infect the respiratory organs.52
Introduction
Pasteurella multocida is a highly invasive bacterium
which causes fowl cholera in turkeys, chicken,and other
avian species (Rhcades and Rimler, 1991).Death often
results from septicemia, but in some bird, chronic
disseminated pasteurellosis can occur (Lucan, 1961).
Pneumonia and airsacculitis are often found in turkeys with
fowl cholera; however, morphological description of P.
multocida- induced acute experiment pneumonia and
airsacculitis in the turkeys are lacking (Arya, 1971).
There are conflicting reports on whetheror not P.
multocida caused persistent bacteremia and whetherthe
bacterial replication occurrs intracellularor extracellular
(Pab-Garnon and Scltys, 1971; Snipes et al., 1987; Tsujiand
Matsumoto, 1989).The site of bacterial replication and the
associated tissue lesions have not been adequately
described.The significance of phagocytosis and bacterial
killing by either heterophiles or macrophage also isnot
known. Rhoades (1964) reported that when P. multocida strain
X-73 inoculated via the nasal cleft, the lung of infected
birds revealed moderate to general infiltration of
interstitial tissue with heterophiles and intravascular of
this cell.Prantner et al.(1990) observed a
fibrinopurulent bronchopneumonia followed ty severe
pulmonary necrosis, pleuritis and vasculitis when a field
isolate was inoculated via oculo-nasal-oral route.Ficken53
and Barnes (1990)inoculated CU strain of P.multocida into
the caudal thoracic airsac and found that the airsacreacted
rapidly and intensively with exudation and accumulationof
heterophils.Kenneth et al.(1990) reported that P.
multocida strain M-9, CU and 86-1913were capable of
generating chemotactic factor when exposed to pooledturkey
serum in vitro.
In natural field infection of turkeys, the respiratory
tract is probably the initial site of infection.The
present study was designed to investigate the invasiveand
persisting ability of two strains of P. multocida,P-1059
and M-9, in various tissues after their intratracheal
inoculation.54
Materials and Methods
Experimental Turkeys: Medium white turkeys were raised
in a closed flock at the Department of Poultry Science,
Oregon State University (Hales, 1989) untilseven weeks of
age.Poultry were raised under conventional management in a
room partitioned by wooden walls with curtainwindows.No
vaccines were administered and no disease problem was noted
during the growing period.At 7 weeks of age, they were
transferred to concrete animal isolation units withwood
shavinglitter on the floor.
Bacteria: P. multocida strain P-1059 and M-9 were
originally obtained as described in material and method
section in the previous chapter.Both strains were
propagated on dextrose starch aaar (DSA), harvested in brain
heart infusion broth (BHI) and stored at -70 C.
Inoculation:P. multocida strains were recovered from
frozen cultures to DSA and incubated at 41 C for 5 hrs (P-
1059), or at 35 C for 8 hrs (M-9). Confluent growth was
harvested with 5 ml of BHI broth/plate and enumerated for
viable counts by plating out serial dilutions on DSA.The
culture harvest of each strain diluted1:10 in BHI was used
as inoculum.
Turkey inoculation:An intratracheal inoculation (IT)
technique described in the previous chapter was used for
administration of both P-1059 and M-9 strain.One
milliliter per bird of diluted culture was deposited slowly55
25 cm below the laryngeal cleft via polyethylene tubing.
After the inoculation the head of the turkey was held for 20
second with the mouth open to prevent immediate expulsion )f
the inoculum.
Experimental design: Thirty-five 14-week-old turkeys
were randomly assigned to three groups as follows:
Experiment 5: Seven control birds were inoculated IT
with 1 ml broth heart infusion (BHI) per bird.
Experiment 6:Fourteen experimental turkeys were IT
inoculated containing 1,2 X 10' CFU of P-1059 per bird.
Experiment 7:Fourteen experimental turkeys were
inoculated similarly with 2.1 X 109 CFU of M-9 strain per
bird.
At 0,0.25, 0.5,1,2,3, and 6 hrs postinoculation,
one turkey from control bird and 2 turkeys from each
challenge group were euthanatized forhistopathological
evaluation.
Histopathology: The turkeys were killed by electrical
shock. At necropsy, the skin of neck was pulled back and tie
trachea was exposed. Three tracheal samples were taken; 2.3
cm below the laryngeal cleft (upper trachea); 2.5 cm above
the bifurcation (lower trachea); and the mid point between
upper and lower trachea. The abdominal cavity of each bird
was opened and airsac and left and right lung were taken.
During the sample processing, macroscopic lesions were
examined.Samples were taken from the right and left lung,56
airsac and upper, middle and lower trachea at 0,0.25, 0.5,
1,2,3,and 6 hrs PI.These samples were placed in 10'-'=,
neutral buffered formalin solution.The tissues were
processed, stained with hematoxylin and eosin according to
standard procedures, and examined by light microscopy.
Section Evaluation:The right and left lung were
evaluated for heterophil infiltration, edema, vascular
changes and lymphocyte infiltration.The airsac was
evaluated for heterophil infiltration, lymphocyte
infiltration, and thickness. The trachea was evaluated for
heterophil infiltration, changes in ciliated epithelium, ald
changes in mucous glands.The severity of the lesions were
indicated as follows: (-)= no lesion;(+)= rare;(++)=
mild;(+++)= severe;(++++)= very severe.
Statistical analysis: The degree of lesions were
analyzed by using the Categorical Data Analysis.57
Results
Experiment 5.In birds inoculated with the BHI broth,
generally no change was observed in tissue samples (Fig
III.1 and 2).But occasionally heterophils were present in
intra or extra vascular of respiratory tissue sampleswith
varying intensity.
Experiment 6.After a variety time of inoculation, all
the birds showed both macroscopic and microscopic lesions.
Macroscopically, the lesion was observed as earlyas 1 hr
after inoculation.Affected small areas of the lung were
foamy and had yellowish purulent exudates, and commonlypus
was squeezed out.The airsacs typically showed cloudy
spots. By 2 to 6 hrs PI, one fourth to one thirdarea of
either right or left lung showed fibrinous pneumonia with
accumulation of pus. Distal parts along the chest wallwere
most frequently affected. The airsacs increased in thickness
and cloudiness.
Microscopically, in the early infection,(0.25 to 1
hr),lesions were found only slight number infiltration of
heterophils in the lung. The airsacs showed mild edema.In
more severely affected lungs(2 to 6 hrs PI), there was
infiltration and accumulationof a large number of
heterophiles (Fig 111.3).Lymphocytes showed nodular and
diffuse accumulation in the Large focal area, and edema
occurred around vessels (Fig 111.4).
The airsac, examined at6 hrs PI, was increased in58
thickness and cloudiness.There was severe infiltration of
heterophiles in the vessels, intra- and extravascular.
Mesothelial/epithelial showed hyperplasia and edema, and
space was filled with fibrin.
Tracheal changes occurred at 3 to 6 hrs PI and varied
in severity between individual birds.These changes
include hyperplasia of the ciliated epithelium and
heterophil infiltration.Mucous gland was cystic and
hyperplastic (Fig 111.5).Moderate changes consisted of
mild diffuse infiltration of heterophils in intravascularor
perivascular areas of trachea in the mucosa and submucosa .
Experiment 7.Pathological changes induced by the IT
inoculation of M-9 were essentially similar to those of P-
1059 strain. In fact, both at early and later stage of
infection.There was no significant difference in the
reactions observed with the two strains (Table III.1vs
111.2 and Fig 111.6)Fig 111.1.Trachea of a controlled bird, showing
normal ciliated epithelium andmucous gland. HE 100X60
Fig 111.2.Lung of a controlled bird, showingthe
vessels. HE 100Xts-
s r 41
\
Fig 111.3.Lung of a bird infected with P-1059strain,3
hrs postinoculation (PI), showing edemaand heterophil
infiltration in pulmonary vessel. HE 250X3 2
Fig 111.4.Trachea of a bird infected withP-1059
strain,6 hrs PI,showing cystic mucous gland.HE 400XFig 111.5.Lung of a bird infected with P-1059strain,6
hrs PI, showing edema and heterophilsinfiltration in
pulmonary vessels. HE 400XFig 111.6.Airsac of a bird infected with M-9strain,6
hrs PI,showing numerous heterophil infiltrations.HE 400X65
Table III.1. Summary of the lesions in the tissues
intratracheally inoculation with P-1059
after
Time(hrs)
Tissues &
Lesions 0 0.25 0.5 1 2 3 6
Lung
Het. inflt.1 ++ +++ ++++
Lymph. inflt.2 + + + ++ ++
Vessels3 + + + + + +
Edema4 + + + + +
Trachea
Het. inflt.
Cil. epith.53.b +
+
+
++
++
++
++
++
++
Mucous glands6 + + + + + +
Airsac
Het. inflt. + + ++ +++ +++ ++++
Lymph. inflt. + + + + + +
Thickening + + ++ ++ ++
= negative. +)= rare. '41= mild. = severe.
++++) = very severe.
1 Heterophileinfiltration
2Lymphocyte infiltration
3Heterophil infiltration
4Vessels
5Ciliate epithelium,
aHeterophile infiltration and
bIntact/Hyperplasia
6cystic/hyperplasia66
Table 111.2. Summary of the lesions in the tissues
intratracheally inoculation with M-9
after
Tissues &
Time(hrs)
Lesions 0 0.25 0.5 1 2 3 6
Lung
Het. inflt.1 + + + + ++ +++ ++++
Lymph. inflt.2 + + + + ++ ++
Vessels3 + + +
Edema4 + + + + +
Trachea
Het. inflt.
Cil. epith.5'''b +
+
+
+
+
++
++
++
++
++
++
Mucous glands6 + + + + + +
Airsac
Het. inflt. + + ++ +++ +++ ++++
Lymph. inflt. + + + + + +
Thickening ++ ++ ++ ++
-)= negative. +)= rare. "-)= mild."4) = severe.
'+++)= very severe.
1 Heterophile infiltration
2 Lymphocyte infiltration
3 Heterophil infiltration
4 Vessels
5 Ciliate epithelium,
aHeterophile infiltration and
bIntact/Hyperplasia
6 cystic/hyperplasia67
Discussion
Fowl cholera is caused by strains of :Pasteurella
multocida that belong to capsular type A and varioussomatic
types.The organisms isolated from turkeys predominantly
belong to type 3 cr type 3,4 (Rhoades and Rimier, 1991).
However, it is generally accepted thatserotype specificity
has no correlation with virulence of organism.Thus, among
strains belonging to somatic type of 3,4, Thereare very
virulent strains and those of low virulence; thelatter
include M-9 vaccine strain (Prantner et al., 1990).In the
Chapter II, we examined the invasiveness and persistenceof
virulent or vaccine strain of P. multocida aftertheir
intratracheal inoculation into turkeys and found that
significant difference among strainswas detected in their
persistence in various tissues but not their invasiveness.
In the present investigation, we comparedIwo strains, a
virulent P-1059 and M-9 vaccine strain, in :heir
pathological responses after their IT inoclationinto
turkeys
In the early course of infection (0.25 to 1 hr),
trachea samples showed cystic in mucous gland followed by
infiltration of heterophils in the epithelial layer.In the
lung, edema of vessels and varying degrees of heterophil and
lymphocyte infiltration were seen. Airsacs were thickened
and infiltrated by heterophils.At later stages, the
lesions were essentially similar in nature, but severe in68
intensity and extended over larger areas.
The statistical analysis indicates there isno
significant difference in these pathological lesionsbetween
birds infected with P-1059 strain and those infectedwith M-
9 strain (Table I1.1 and 11.2).Prantner et al.(1990) also
compared pathological changes in turkeys inoculated witha
virulent strain with those inoculated witha nonvirulent
strain.After oculo-nasal exposure to these organism, they
observed significant differences in lesionscores only at
some stage of infection.However, there were no qualitative
differences in the pathological changes caused byvirulent
or vaccine strains.The results in the present study
essentially confirm their results.
Some control birds that had received BHI broth showed
mild degrees of heterophil infiltration in respiratory
tissues.Although the experimental turkeys were raised
under isolated condition without any vaccination, theywere
not reared under filtered air or with sterilized feed.
Therefore, some subclinical infection of the respiratory
tract may have occurred.Since the infiltration of
heterophils is one of the major histopathological changes
for P. multocida infection, pre-existed lesions obscure the
early lesions induced by the organism.However, at later
stages of infection, both strains induced such massive scale
of hetrophil infiltration, the presence of a minor degree of
inflammation before infections does not have a major impact69
on interpreting pathological lesions.
Edema and heterophil infiltration are major changes in
the respiratory tissues after the inoculation of P.
multocida.The organism produces endotoxin whichmay be
diffused into tissues, causing edema and necrosis(Rhoades,
1964). The heterophil infiltrationmay be caused by a
chemotactic factor described by Kenneth et al.(1990). Since
both P-1059 and M-9 strain produced essentially identical
histological changes, it can be concluded that both strains
produce these pathogenic factors in a similarmanner.
However, as indicated in the previous chapter, M-9 strain
does not persist in tissues as well as P-1059 does.The
reason for the poor persistence is unknown other than the
fact that M-9 strain does not multiply wellat 41 C.Many
investigators have indicated the M-9 strain has
significantly lower virulence than 9-1059 straindoes 9
(snipe et al., 1987).However, the present results suggest
that both strains induce very similar pathological changes
in turkeys when fairly large doses of the organismare
introduced into trachea.70
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